Biotechnology and the utilitarian argument for patents.
D000383:Agriculture; D035843:Biomedical Research; D020811:Biomedical Technology; D003362:Cost-Benefit Analysis; D004274:DNA, Recombinant; D003906:Developing Countries; D004467:Economics; D028663:Ethical Theory; D004989:Ethics; D035082:Federal Government; D005380:Financing, Government; D005796:Genes; D036281:Genetic Research; D005823:Genetics; D006076:Government; D015276:Health Care Rationing; D006801:Humans; D007221:Industry; D033181:Information Dissemination; D007255:Information Services; D009042:Motivation; D030781:Organisms, Genetically Modified; D010330:Patents as Topic; D011640:Public Policy; D012106:Research; D040841:Resource Allocation; D012306:Risk; D018570:Risk Assessment; D012586:Science; D012922:Social Change; D014481:United States; D014495:Universities
Biomedical and Behavioral Research; Genetics and Reproduction